13
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Streptococcus Species Abundance in the Gut Is Linked to Subclinical Coronary Atherosclerosis in 8973 Participants From the SCAPIS Cohort

      research-article
      , PhD * , , MSc * , , MD, , DDS, PhD, , BSc, , MD, PhD, , PhD, , PhD, , DVM, , MSc, , MSc, , PhD, , PhD, , PhD, , PhD, , PhD, , PhD, , MD, , DDS, PhD, , DDS, PhD, , MD, PhD, , MD, PhD, , MD, PhD, , MD, PhD, , MD, PhD, , MD, PhD, , MD, PhD, , MD, PhD, , PhD , , DVM, PhD ,
      Circulation
      Lippincott Williams & Wilkins
      atherosclerosis, gastrointestinal microbiome, metagenomics, Streptococcus, tomography

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          BACKGROUND:

          Gut microbiota have been implicated in atherosclerotic disease, but their relation with subclinical coronary atherosclerosis is unclear. This study aimed to identify associations between the gut microbiome and computed tomography–based measures of coronary atherosclerosis and to explore relevant clinical correlates.

          METHODS:

          We conducted a cross-sectional study of 8973 participants (50 to 65 years of age) without overt atherosclerotic disease from the population-based SCAPIS (Swedish Cardiopulmonary Bioimage Study). Coronary atherosclerosis was measured using coronary artery calcium score and coronary computed tomography angiography. Gut microbiota species abundance and functional potential were assessed with shotgun metagenomics sequencing of fecal samples, and associations with coronary atherosclerosis were evaluated with multivariable regression models adjusted for cardiovascular risk factors. Associated species were evaluated for association with inflammatory markers, metabolites, and corresponding species in saliva.

          RESULTS:

          The mean age of the study sample was 57.4 years, and 53.7% were female. Coronary artery calcification was detected in 40.3%, and 5.4% had at least 1 stenosis with >50% occlusion. Sixty-four species were associated with coronary artery calcium score independent of cardiovascular risk factors, with the strongest associations observed for Streptococcus anginosus and Streptococcus oralis subsp oralis ( P<1×10 –5). Associations were largely similar across coronary computed tomography angiography–based measurements. Out of the 64 species, 19 species, including streptococci and other species commonly found in the oral cavity, were associated with high-sensitivity C-reactive protein plasma concentrations, and 16 with neutrophil counts. Gut microbial species that are commonly found in the oral cavity were negatively associated with plasma indole propionate and positively associated with plasma secondary bile acids and imidazole propionate. Five species, including 3 streptococci, correlated with the same species in saliva and were associated with worse dental health in the Malmö Offspring Dental Study. Microbial functional potential of dissimilatory nitrate reduction, anaerobic fatty acid β-oxidation, and amino acid degradation were associated with coronary artery calcium score.

          CONCLUSIONS:

          This study provides evidence of an association of a gut microbiota composition characterized by increased abundance of Streptococcus spp and other species commonly found in the oral cavity with coronary atherosclerosis and systemic inflammation markers. Further longitudinal and experimental studies are warranted to explore the potential implications of a bacterial component in atherogenesis.

          Related collections

          Most cited references45

          • Record: found
          • Abstract: not found
          • Article: not found

          Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Fast gapped-read alignment with Bowtie 2.

            As the rate of sequencing increases, greater throughput is demanded from read aligners. The full-text minute index is often used to make alignment very fast and memory-efficient, but the approach is ill-suited to finding longer, gapped alignments. Bowtie 2 combines the strengths of the full-text minute index with the flexibility and speed of hardware-accelerated dynamic programming algorithms to achieve a combination of high speed, sensitivity and accuracy.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019

              Cardiovascular diseases (CVDs), principally ischemic heart disease (IHD) and stroke, are the leading cause of global mortality and a major contributor to disability. This paper reviews the magnitude of total CVD burden, including 13 underlying causes of cardiovascular death and 9 related risk factors, using estimates from the Global Burden of Disease (GBD) Study 2019. GBD, an ongoing multinational collaboration to provide comparable and consistent estimates of population health over time, used all available population-level data sources on incidence, prevalence, case fatality, mortality, and health risks to produce estimates for 204 countries and territories from 1990 to 2019. Prevalent cases of total CVD nearly doubled from 271 million (95% uncertainty interval [UI]: 257 to 285 million) in 1990 to 523 million (95% UI: 497 to 550 million) in 2019, and the number of CVD deaths steadily increased from 12.1 million (95% UI:11.4 to 12.6 million) in 1990, reaching 18.6 million (95% UI: 17.1 to 19.7 million) in 2019. The global trends for disability-adjusted life years (DALYs) and years of life lost also increased significantly, and years lived with disability doubled from 17.7 million (95% UI: 12.9 to 22.5 million) to 34.4 million (95% UI:24.9 to 43.6 million) over that period. The total number of DALYs due to IHD has risen steadily since 1990, reaching 182 million (95% UI: 170 to 194 million) DALYs, 9.14 million (95% UI: 8.40 to 9.74 million) deaths in the year 2019, and 197 million (95% UI: 178 to 220 million) prevalent cases of IHD in 2019. The total number of DALYs due to stroke has risen steadily since 1990, reaching 143 million (95% UI: 133 to 153 million) DALYs, 6.55 million (95% UI: 6.00 to 7.02 million) deaths in the year 2019, and 101 million (95% UI: 93.2 to 111 million) prevalent cases of stroke in 2019. Cardiovascular diseases remain the leading cause of disease burden in the world. CVD burden continues its decades-long rise for almost all countries outside high-income countries, and alarmingly, the age-standardized rate of CVD has begun to rise in some locations where it was previously declining in high-income countries. There is an urgent need to focus on implementing existing cost-effective policies and interventions if the world is to meet the targets for Sustainable Development Goal 3 and achieve a 30% reduction in premature mortality due to noncommunicable diseases.
                Bookmark

                Author and article information

                Contributors
                Journal
                Circulation
                Circulation
                CIR
                Circulation
                Lippincott Williams & Wilkins (Hagerstown, MD )
                0009-7322
                1524-4539
                12 July 2023
                08 August 2023
                : 148
                : 6
                : 459-472
                Affiliations
                [1]Molecular Epidemiology and Science for Life Laboratory (S.S.-B., K.F.D., G. Baldanzi, U.H., Y.-T.L., S.A., D.N., G.V., T.F.), Department of Medical Sciences, Uppsala University, Sweden.
                [2]Clinical Physiology (A.M.), Department of Medical Sciences, Uppsala University, Sweden.
                [3]Clinical Epidemiology (L.L., J.S.), Department of Medical Sciences, Uppsala University, Sweden.
                [4]CIBER Cardiovascular Diseases (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain (S.S.-B.).
                [5]Department of Clinical Sciences in Malmö, Lund University, Sweden (D.J., U.E., L.B., F.O., A.L., P.M.N., G.E., M.O.-M.).
                [6]Public Dental Service of Skåne, Lund, Sweden (D.J.).
                [7]Departments of Periodontology (D.J., B.K.), Faculty of Odontology, Malmö University, Sweden.
                [8]Cariology (D.E.), Faculty of Odontology, Malmö University, Sweden.
                [9]Division of Family Medicine and Primary Care, Department of Neurobiology, Care Science and Society, Karolinska Institutet, Huddinge, Sweden (Y.-T.L., J.Ä.).
                [10]Preventive Medicine Division, Harvard Medical School, Brigham and Women’s Hospital, Boston, MA (S.A.).
                [11]Clinical Microbiomics A/S, Copenhagen, Denmark (S.P., N.N., A.C.E., J.B.H., H.B.N.).
                [12]The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Lyngby, Denmark (S.P.).
                [13]Clinical Studies Sweden, Forum Söder, Region Skåne, Lund, Sweden (L.B.).
                [14]Section for Clinical Mass Spectrometry, Danish Center for Neonatal Screening, Department of Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark (F.O.).
                [15]Department of Dental Medicine, Karolinska Institutet, Solna, Sweden (B.K.).
                [16]Department of Internal Medicine, Skåne University Hospital, Malmö, Sweden (P.M.N.).
                [17]Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Sweden (G. Bergström).
                [18]Department of Clinical Physiology, Sahlgrenska University Hospital, Region Västra Götaland, Gothenburg, Sweden (G. Bergström).
                [19]The George Institute for Global Health, University of New South Wales, Sydney, Australia (J.S.).
                [20]School of Health and Social Studies, Dalarna University, Falun, Sweden (J.Ä.).
                [21]The Wallenberg Laboratory/Department of Molecular and Clinical Medicine, Institute of Medicine, Gothenburg University, Sweden (J.G.S.).
                [22]Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden (J.G.S.).
                [23]Department of Cardiology, Clinical Sciences, and Wallenberg Center for Molecular Medicine and Lund University Diabetes Center, Lund University, Sweden (J.G.S.).
                [24]Skåne University Hospital, Lund, Sweden (J.G.S.).
                Author notes
                Correspondence to: Tove Fall, PhD, Professor in Molecular Epidemiology, Department of Medical Sciences, Molecular Epidemiology, Uppsala University, EpiHubben, MTC-huset, 75185, Uppsala, Sweden. Email tove.fall@ 123456medsci.uu.se
                Author information
                https://orcid.org/0000-0002-1181-6262
                https://orcid.org/0000-0001-8298-539X
                https://orcid.org/0000-0002-3873-7943
                https://orcid.org/0000-0002-9680-5772
                https://orcid.org/0000-0002-3320-2448
                https://orcid.org/0000-0002-5163-7306
                https://orcid.org/0000-0003-0861-1001
                https://orcid.org/0000-0003-1756-0875
                https://orcid.org/0000-0003-2281-5713
                https://orcid.org/0000-0003-0356-2351
                https://orcid.org/0000-0002-5652-8459
                https://orcid.org/0000-0002-4098-7765
                https://orcid.org/0000-0003-2335-8542
                https://orcid.org/0000-0003-4289-5722
                https://orcid.org/0000-0003-2247-8454
                https://orcid.org/0000-0002-6933-4637
                https://orcid.org/0000-0002-8618-9152
                https://orcid.org/0000-0001-6285-9935
                https://orcid.org/0000-0002-3578-2503
                https://orcid.org/0000-0003-2071-5866
                Article
                00002
                10.1161/CIRCULATIONAHA.123.063914
                10399955
                37435755
                45b79c78-55c8-45cd-898c-8deb12b78898
                © 2023 The Authors.

                Circulation is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited.

                History
                : 10 January 2023
                : 12 June 2023
                Categories
                10030
                10058
                10062
                10085
                10189
                Original Research Articles
                Custom metadata
                TRUE
                T

                atherosclerosis,gastrointestinal microbiome,metagenomics,streptococcus,tomography

                Comments

                Comment on this article